Cisplatin plus VP 16-213 in advanced ovarian carcinoma.

Harnett, P R

Cisplatin plus VP 16-213 in advanced ovarian carcinoma. [electronic resource] - Gynecologic oncology Jun 1988 - 159-62 p. digital

Publication Type: Journal Article

0090-8258

10.1016/0090-8258(88)90019-4 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bone Marrow--drug effects
Carcinoma--drug therapy
Cisplatin--administration & dosage
Depression, Chemical
Drug Evaluation
Etoposide--administration & dosage
Female
Humans
Middle Aged
Ovarian Neoplasms--drug therapy
Time Factors